Wilterding Mark
Insider CIK 2107187 · RXST Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXST RxSight, Inc. | A Award deriv | 2026-09-05 | 2026-09-09 | 258,770 | — | $0 | 258,770 | SEC↗ |
| RXST RxSight, Inc. | D To issuer deriv | 2026-09-05 | 2026-09-09 | 258,770 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | A Award deriv | 2026-09-05 | 2026-09-09 | 258,770 | — | — | 258,770 | SEC↗ |
| RXST RxSight, Inc. | D To issuer deriv | 2026-09-05 | 2026-09-09 | 258,770 | — | — | 0 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2026-09-02 | 2026-09-02 | 7,765 | $6.96 | $54.0K | 25,049 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2026-09-02 | 2026-09-02 | 7,765 | $6.96 | $54.0K | 25,049 | SEC↗ |
| RXST RxSight, Inc. | M Exercise deriv | 2026-08-31 | 2026-09-02 | 20,441 | — | $0 | 122,646 | SEC↗ |
| RXST RxSight, Inc. | M Exercise | 2026-08-31 | 2026-09-02 | 20,441 | — | $0 | 32,814 | SEC↗ |
| RXST RxSight, Inc. | M Exercise deriv | 2026-08-31 | 2026-09-02 | 20,441 | — | $0 | 122,646 | SEC↗ |
| RXST RxSight, Inc. | M Exercise | 2026-08-31 | 2026-09-02 | 20,441 | — | — | 32,814 | SEC↗ |
| RXST RxSight, Inc. | M Exercise deriv | 2026-02-28 | 2026-03-03 | 20,441 | — | $0 | 143,087 | SEC↗ |
| RXST RxSight, Inc. | F Tax w/h | 2026-02-28 | 2026-03-03 | 8,068 | $7.61 | $61.4K | 12,373 | SEC↗ |
| RXST RxSight, Inc. | M Exercise | 2026-02-28 | 2026-03-03 | 20,441 | — | $0 | 20,441 | SEC↗ |
| RXST RxSight, Inc. | A Award deriv | 2026-01-12 | 2026-01-30 | 163,528 | — | $0 | 163,528 | SEC↗ |
| RXST RxSight, Inc. | A Award deriv | 2026-01-12 | 2026-01-30 | 258,770 | — | $0 | 258,770 | SEC↗ |